Related content

Peptide receptor radionuclide therapy with 90 Y-DOTATOC in recurrent meningioma

By Bartolomei Mirco  

European Journal of Nuclear Medicine and Molecular Imaging, Vol. 36, Iss. 9, 2009-09 ,pp. : 1407-1416

Springer Publishing Company

Access to resources Recommend Favorite

Receptor radionuclide therapy with ⁹⁰Y-[DOTA]⁰-Tyr³-octreotide (⁹⁰Y-DOTATOC) in neuroendocrine tumours

By Bodei Lisa   Cremonesi Marta   Grana Chiara   Rocca Paola   Bartolomei Mirco   Chinol Marco   Paganelli Giovanni  

European Journal of Nuclear Medicine and Molecular Imaging, Vol. 31, Iss. 7, 2004-07 ,pp. : 1038-1046

Springer Publishing Company

Access to resources Recommend Favorite

A comparison of ¹¹¹In-DOTATOC and ¹¹¹In-DOTATATE: biodistribution and dosimetry in the same patients with metastatic neuroendocrine tumours

By Forrer F.   Uusijärvi H.   Waldherr C.   Cremonesi M.   Bernhardt P.   Mueller-Brand J.   Maecke H.  

European Journal of Nuclear Medicine and Molecular Imaging, Vol. 31, Iss. 9, 2004-09 ,pp. : 1257-1262

Springer Publishing Company

Access to resources Recommend Favorite

Comparison of ⁶⁸Ga-DOTATOC PET and ¹¹¹In-DTPAOC (Octreoscan) SPECT in patients with neuroendocrine tumours

By Buchmann I.   Henze M.   Engelbrecht S.   Eisenhut M.   Runz A.   Schäfer M.   Schilling T.   Haufe S.   Herrmann T.   Haberkorn U.  

European Journal of Nuclear Medicine and Molecular Imaging, Vol. 34, Iss. 10, 2007-10 ,pp. : 1617-1626

Springer Publishing Company

Access to resources Recommend Favorite

The dosimetric importance of the number of ⁹⁰Y microspheres in liver transarterial radioembolization (TARE)

By Spreafico Carlo   Maccauro Marco   Mazzaferro Vincenzo   Chiesa Carlo  

European Journal of Nuclear Medicine and Molecular Imaging, Vol. 41, Iss. 4, 2014-04 ,pp. : 634-638

Springer Publishing Company

Access to resources Recommend Favorite